From The Mass Spec Continuum To AI-Enabled Developability Insights

By Justyna Lisowska, PhD, Science & Technology Manager, and Stephen KoK, Head of US Scientific Consulting, Genedata

This content is brought to you by Genedata, a Danaher Operating Company.

A typical monoclonal antibody has 20 to 30 critical quality attributes to assess, and bi-specifics, fusion proteins, and conjugates add further analytical load. Mass spectrometry is increasingly positioned as a continuous thread running from discovery through QC, rather than a specialist characterization tool. The harder question is what makes its data usable at portfolio scale, and what AI-driven decision support actually requires underneath it.

Access the full article to examine where the multi-attribute method fits and why the evidence behind a prediction matters as much as the model.